Liminatus Pharma, Inc. · NASDAQ:LIMN

Valetudo Therapeutics LLC reported a 23.70% stake in Liminatus Pharma, Inc. (Schedule 13D)

Event Apr 30, 2025 · Filed May 7, 2025

Valetudo Therapeutics LLC reported a 23.70% stake in Liminatus Pharma, Inc., 6,169,406 shares, with active intent on Apr 30, 2025. Filed May 7, 2025 (Schedule 13D).

Stake
23.70%
Shares
6,169,406
Intent
Active
What changed
Crossed above 5%
Filed together
2 holders

The filing in full

HolderStakeShares
Valetudo Therapeutics LLC23.70%6,169,406
Chris Kim23.70%6,169,406

Source

View original at SEC

Related